ZEST, NCT04915755 / 2020-003973-23: Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease |
|
|
| Active, not recruiting | 3 | 43 | Europe, Canada, Japan, US, RoW | Niraparib, Placebo | GlaxoSmithKline | Neoplasms, Breast | 06/24 | 12/25 | | |
NCT06771076: Effects of a CBD and Natural Ingredients Cream on the Chronic Pain of Triathletes |
|
|
| Recruiting | N/A | 47 | Europe | Cream with CBD and natural ingredients, Cream with CBD, Cream without CBD and natural ingredients, Cream without CBD | University of Vic - Central University of Catalonia, Uriach Consumer Healthcare | Tendinopathy, Injuries, Chronic Pain, Sports, Physical Activity | 04/25 | 04/25 | | |
